Bionyra

Bionyra Pharma

Bionyra Pharma develops mono and multispecific antibodies for patients with severe immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Belenos Biosciences

This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.

Infinimmune

This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.

Edesa Biotech

This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.

SciRhom

This biopharmaceutical company develops monoclonal antibodies targeting iRhom2 to treat patients with autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Biond Biologics

This biopharmaceutical company develops antibody-based immunotherapies and intracellular delivery platforms for patients with cancer and immune-mediated diseases.